SMS Pharmaceuticals (NSE:SMSPHARMA) E10: ₹7.18 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SMSPHARMA SMS Pharmaceuticals Ltd NSE:SMSPHARMA
78 GF Score
Price ₹363.55
GF Value ₹278.49
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SMS Pharmaceuticals E10?

SMS Pharmaceuticals NSE:SMSPHARMA -2.77% 78 E10 is ₹7.18 as of Jun. 2026. GuruFocus rates NSE:SMSPHARMA with a GF Score™ of 78/100 and a GF Value™ of ₹278.49 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

SMS Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹2.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹7.18 for the trailing ten years ended in Jun. 2026.

During the past 12 months, SMS Pharmaceuticals's average E10 Growth Rate was 11.40% per year. During the past 3 years, the average E10 Growth Rate was 8.30% per year. During the past 5 years, the average E10 Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of SMS Pharmaceuticals was 8.30% per year. The lowest was 4.10% per year. And the median was 4.10% per year.

As of today (2026-08-04), SMS Pharmaceuticals's current stock price is ₹363.55. SMS Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 was ₹7.18. SMS Pharmaceuticals's Shiller PE Ratio of today is 50.63.

During the past 13 years, the highest Shiller PE Ratio of SMS Pharmaceuticals was 60.91. The lowest was 10.47. And the median was 27.75.


SMS Pharmaceuticals  (NSE:SMSPHARMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

SMS Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=363.55/7.18
=50.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of SMS Pharmaceuticals was 60.91. The lowest was 10.47. And the median was 27.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


SMS Pharmaceuticals E10 Related Terms


SMS Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for SMS Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMS Pharmaceuticals E10 Chart

SMS Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.56 5.56 5.72 6.30 7.02

SMS Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.46 6.74 6.83 7.02 7.18

NSE:SMSPHARMA vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SMS Pharmaceuticals's Shiller PE Ratio falls into.


NSE:SMSPHARMA
78GF Score
SMS Pharmaceuticals Ltd NSE:SMSPHARMA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SMS Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SMS Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.23/166.1454*166.1454
=2.230

Current CPI (Jun. 2026) = 166.1454.

SMS Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201509 1.240 101.753 2.025
201512 1.300 102.901 2.099
201603 1.440 102.518 2.334
201606 1.080 105.961 1.693
201609 1.340 105.961 2.101
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 0.850 111.317 1.269
201809 1.190 115.142 1.717
201812 1.110 115.142 1.602
201903 1.580 118.202 2.221
201906 0.920 120.880 1.265
201909 1.170 123.175 1.578
201912 0.900 126.235 1.185
202003 0.760 124.705 1.013
202006 0.830 127.000 1.086
202009 1.300 130.118 1.660
202012 2.530 130.889 3.211
202103 2.740 131.771 3.455
202106 2.780 134.084 3.445
202109 2.720 135.847 3.327
202112 1.070 138.161 1.287
202203 0.760 138.822 0.910
202206 -1.510 142.347 -1.762
202209 -0.240 144.661 -0.276
202212 0.440 145.763 0.502
202303 0.420 146.865 0.475
202306 1.100 150.280 1.216
202309 1.390 151.492 1.524
202312 1.360 152.924 1.478
202403 2.050 153.035 2.226
202406 1.950 155.789 2.080
202409 1.670 157.882 1.757
202412 2.150 158.323 2.256
202503 2.400 157.552 2.531
202506 2.310 159.755 2.402
202509 2.840 162.289 2.907
202512 2.590 163.281 2.635
202603 3.580 164.272 3.621
202606 2.230 166.145 2.230

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹7.18 mean?
SMS Pharmaceuticals (NSE:SMSPHARMA) has a E10 of ₹7.18 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on SMS Pharmaceuticals and its competitors.
Is SMS Pharmaceuticals' E10 too high?
SMS Pharmaceuticals' current E10 is ₹7.18. Overall, SMS Pharmaceuticals has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SMS Pharmaceuticals' E10 compare to LLY and JNJ?
SMS Pharmaceuticals' E10 of ₹7.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on SMS Pharmaceuticals and its competitors. SMS Pharmaceuticals's current E10 is ₹7.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SMS Pharmaceuticals (NSE:SMSPHARMA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹278.49, compared to a current price of ₹363.55 — trading 30.5% above its estimated fair value. The current E10 is ₹7.18. SMS Pharmaceuticals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For SMS Pharmaceuticals (NSE:SMSPHARMA), the current E10 is ₹7.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SMS Pharmaceuticals (NSE:SMSPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued. The current stock price of ₹363.55 is trading 30.5% above its estimated GF Value™ of ₹278.49. GuruFocus considers SMS Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:SMSPHARMA:

  • E10: ₹7.18
  • GF Value™: ₹278.49 vs. price of ₹363.55 (30.5% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the NSE:SMSPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SMS Pharmaceuticals Business Description

Other Exchanges 532815:India
Address Road. No. 5, Plot No. 72, H.No. 8-2-334 / 3 & 4, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad, TG, IND, 500034
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
78GF Score

Get the complete analysis for NSE:SMSPHARMA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹363.55
Price
₹278.49
GF Value